CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase

class of enzymes

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionJun 12, 2026
Entity authorityQ7030558 ↗
Source-derived summary

Nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase (EC 2.4.2.21) is an enzyme that catalyzes the chemical reaction

nicotinate mononucleotide + 5,6-dimethylbenzimidazole

⇌

{\displaystyle \rightleftharpoons }

nicotinic acid + α-ribazole 5'-phosphate

The reaction is part of the biosynthesis of cobalamin (a form of vitamin B12) in bacteria.

This enzyme is a glycosyltransferase, specifically a pentosyltransferase. The systematic name of this enzyme class is nicotinate-nucleotide:5,6-dimethylbenzimidazole phospho-D-ribosyltransferase. Other names in common use include CobT, nicotinate mononucleotide-dimethylbenzimidazole phosphoribosyltransferase, nicotinate ribonucleotide:benzimidazole (adenine) phosphoribosyltransferase, nicotinate-nucleotide:dimethylbenzimidazole phospho-D-ribosyltransferase, and nicotinate mononucleotide (NaMN):5,6-dimethylbenzimidazole phosphoribosyltransferase.

Function

This enzyme plays a central role in the synthesis of α-ribazole 5'-phosphate, an intermediate for the lower ligand of cobalamin. It is one of the enzymes in the anaerobic pathway of cobalamin biosynthesis, and one of the four proteins (CobU, CobT, CobC, and CobS) involved in the synthesis of the lower ligand and the assembly of the nucleotide loop. The reaction replaces the nicotinic acid group in nicotinate mononucleotide by reaction with 5,6-dimethylbenzimidazole (5,6-DMB), with inversion of stereochemistry.

Biosynthesis of cobalamin

Vitamin B12 (cobalamin) is used as a cofactor in a number of enzyme-catalysed reactions in bacteria, archaea and eukaryotes. The biosynthetic pathway to adenosylcobalamin from its five-carbon precursor, 5-aminolaevulinic acid, can be divided into three sections: (1) the biosynthesis of uroporphyrinogen III from 5-aminolaevulinic acid; (2) the conversion of uroporphyrinogen III into the ring-contracted, deacylated intermediate precorrin 6 or cobalt-precorrin 6; and (3) the transformation of this intermediate to form adenosylcobalamin. Cobalamin is synthesised by bacteria and archaea via two alternative routes that differ primarily in the steps of section 2 that lead to the contraction of the macrocycle and excision of the extruded carbon molecule (and its attached methyl group).

Editorial summary

Begin with the source’s own compact description: “Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase” is class of enzymes. The dossier treats that line as a proposition to test through Nicotinate-nucleotide, dimethylbenzimidazole and phosphoribosyltransferase, not as a finished interpretation.

Editorial reviewA concise reference frame for defining the subject, testing terminology and identifying the institution closest to the evidence. The current 273-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. For this dossier, Nicotinate-nucleotide, dimethylbenzimidazole and phosphoribosyltransferase is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “class of enzymes” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jun 12, 2026. The linked authority identifier is Q7030558. None of the 0 selected statements returned an explicit reference.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase”, its source revision and the description used here.
  2. Expand the search: follow Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase primary sources, Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase archive and Nicotinate-nucleotide research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase”?
  2. Which institution is responsible for the underlying evidence?
  3. Which cited source is closest to the event, object or claim?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Nicotinate-nucleotide—dimethylbenzimidazole phosphoribosyltransferase” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.